SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): February 5, 2004
MICROTEK MEDICAL HOLDINGS, INC.
- --------------------------------------------------------------------------------
(Exact Name of Registrant as Specified in Its Charter)
Georgia
(State or Other Jurisdiction of Incorporation)
0-24866 58-1746149
- ---------------------------------- ---------------------------------------
(Commission File Number) (I.R.S. Employer Identification No.)
512 Lehmberg Road; Columbus, Mississippi 39702
- --------------------------------------------------------------------------------
(Address of Principal Executive Offices (Zip Code)
(662) 327-1863
- --------------------------------------------------------------------------------
(Registrant's Telephone Number, Including Area Code)
ITEM 12. RESULTS OF OPERATIONS AND FINANCIAL CONDITIONS
On February 5, 2004, Microtek Medical Holdings, Inc. (the "Company")
issued a press release announcing its anticipated net revenues for the
quarter and year ended December 31, 2003. This press release is
attached as Exhibit 99.1 to this report and is incorporated herein by
reference.
Exhibits:
99.1 Press release dated February 5, 2004, announcing the Company's
anticipated net revenues for the quarter and year ended December
31, 2003
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has caused this report to be duly signed on its behalf by the
undersigned hereunto duly authorized.
MICROTEK MEDICAL HOLDINGS, INC.
By: /s/ Dan R. Lee
---------------------------------------------
Dan R. Lee, Chairman, President and Chief
Executive Officer
By: /s/ Roger G. Wilson
---------------------------------------------
Roger G. Wilson, Chief Financial Officer
Dated: February 5, 2004
1717328